• SENSEX 76,515.43
    362.57 (+0.48%)
  • BANKNIFTY 57,369.65
    -10.95 (--0.02%)
  • Gland Pharma
    2,969.85 3,039.00(%)
  • Power Fin.Corpn.
    357.70 486.45(%)
  • IFCI
    107.45 107.45(%)
  • Shriram Finance
    1,036.40 584.25(%)
  • Tata Technolog.
    796.45 507.50(%)
  • ESDS Software
    895.55 895.55(%)
  • Lenskart Solut.
    694.75 694.75(%)
  • Netweb Technol.
    5,170.00 2,514.75(%)
  • Lumino Inds
    122.00 122.00(%)
  • Kesar India
    1,180.00 1,341.00(%)
  • Multi Comm. Exc.
    3,287.00 3,479.80(%)
  • Tejas Networks
    623.90 644.75(%)
  • RBL Bank
    417.00 417.00(%)
  • ICICI AMC
    2,960.00 2,528.90(%)
  • Polycab India
    8,254.00 6,660.50(%)
  • New India Assura
    234.60 234.60(%)
  • Wockhardt
    2,107.95 2,420.00(%)
  • Angel One
    308.20 360.20(%)
  • Jindal Worldwide
    57.06 57.06(%)
  • Lalithaa Jewel
    308.55 308.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Sai Life Sciences Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 68121.0
  • ISIN : INE570L01029
1,584.30 10 (0.60%)
  • As on 05 Sep 2026 (EOD)

  • Today’s Low

    1,561.90

  • Today’s High

    1,622.00

  • Open

    1,570.00

  • Perv Close

    1,574.80

  • 52W Low

    783.85

  • 52W High

    1,630.00

Key Indicators

  • P/E(TTM)

    93.40

  • Mar.Cap (₹Cr.)

    33,649.62

  • Div & Yield %

    0.00

  • Book Value(₹)

    118.08

  • Debt-Equity Ratio

    0.60

  • AGM Date

    04-Sep-2026

  • EPS

    16.97

  • P/E Ratio

    93.40

Financials Ratios

  • Debt-Equity Ratio

    0.87

  • Mar.Cap (₹Cr.)

    33,649.62

  • RONW (%)

    8.89

  • ROCE (%)

    10.56

Score Board

  • Equity (₹ in Cr.)

    21.24

  • BV (₹)

    118.10

  • Sales( ₹ in Cr.)

    2,153.23

  • NP (in Cr.)

    348.19

  • NP Var(%)

    99.0

  • Div%

    0.0

  • CPS (₹)

    23.60

  • EPS (₹)

    16.40

  • Traded Value (₹ in Lakhs)

    33,664.48

  • 52 Week High

    1,630.00

  • 52 Week Low

    783.85

  • Price BSE

    1585.0

  • Price NSE

    1,584.00

  • Market Capital( in Cr.)

    33,664.48

  • P/C Ratio

    67.30

  • P/E Ratio

    96.70

  • Price Vs.BV

    16.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 2,153.23 1,642.05 1,418.68 1,157.40 841.02 751.47
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 2,153.23 1,642.05 1,418.68 1,157.40 841.02 751.47
Other Income 49.13 37.34 29.33 27.96 28.15 27.29
Stock Adjustments 7.76 -4.13 -23.80 4.59 2.83 16.50
Total Income 2,210.12 1,675.26 1,424.21 1,189.95 872.00 795.26
EXPENDITURE :            
Raw Materials 568.34 445.52 408.78 413.12 251.14 232.69
Power and Fuel Cost 64.63 48.19 49.49 43.73 31.86 27.25
Employee Cost 617.73 485.56 430.63 353.76 263.37 203.64
Other Manufacturing Expenses 130.01 95.35 84.73 90.06 78.21 50.32
Selling and Administration Expenses 199.80 135.20 117.15 84.16 84.59 85.45
Miscellaneous Expenses -12.93 35.76 16.06 10.29 9.79 4.44
Employee Benefit Expenses 617.73 485.56 430.63 353.76 263.37 203.64
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 1,567.57 1,245.57 1,106.84 995.11 718.97 603.79
Operating Profit 642.55 429.69 317.37 194.84 153.03 191.46
Interest 34.08 71.94 81.15 74.38 50.98 32.11
Gross Profit 608.47 357.75 236.22 120.46 102.05 159.35
Depreciation 152.30 126.03 107.21 87.77 79.70 71.77
Profit Before Tax 456.17 231.72 129.01 32.69 22.35 87.58
Current Tax 87.95 33.82 7.97 10.73 9.37 3.73
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 26.74 24.44 25.81 -2.28 -2.70 18.55
Reported Net Profit 341.48 173.46 95.23 24.24 15.68 65.30
Extraordinary Items -6.71 -1.36 0.01 -0.38 11.31 0.00
Adjusted Net Profit 348.19 174.82 95.22 24.62 4.37 65.30
Adjustment below Net Profit 1.26 0.95 1.08 2.39 0.00 0.83
P & L Balance brought forward 768.46 594.05 497.75 478.02 461.76 394.23
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 6.90 -0.58 -0.21
P & L Balance carried down 1,111.21 768.46 594.05 497.75 478.02 460.57
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 383.30 396.30 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 38.33 39.63 0.00
Earnings Per Share-Unit Curr 16.12 8.32 53.92 13.76 8.93 36.65
Earnings Per Share(Adj)-Unit Curr 16.12 8.32 - - - -
Book Value 118.42 104.00 572.28 517.79 507.50 486.92
Book Value(Adj)-Unit Curr 118.42 104.00 - - - -

Shareholding Pattern

  • Promoter Group

    34.53%

  • Public Share Holding

    65.47%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 3,521,560 3,521,560.00 3,521,560 3,521,560
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 3,521,560 1.66 3,521,560 2
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,611,290 2.17 4,611,290 2
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 11,199,905 5.28 11,199,905 4
Partnership Firms-Indian (Promoter & Group) 53,961,920 25.42 53,961,920 4
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 69,773,115 32.87 69,773,115 10
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 660 0.00 660 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 41,713,199 19.65 41,713,199 161
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 6,186,455 2.91 6,186,455 9
Mutual Funds / UTI 62,565,109 29.47 62,565,109 27
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 693,543 0.33 693,543 15
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 111,158,966 52.36 111,158,966 213
2] Non Institution
Bodies Corporate 1,150,056 0.54 1,150,056 413
Clearing Members 160 0.00 160 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 9,559,772 4.50 9,559,772 1,926
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 371,032 0.17 371,032 3,425
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 3,569,615 1.68 3,569,615 9
Individuals holding nominal share capital up to Rs. 1 lakh 10,822,544 5.10 10,652,043 119,089
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 1,241,871 0.59 1,241,871 5
Others 1,117,325 0.53 1,117,325 2
Sub Total 27,832,375 13.11 27,661,874 124,871
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 212,286,016 100.00 212,115,515 125,096

Company Background

Sai Life Sciences LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Sai Life Sciences Ltd
  • BSE Code : 68121.0
  • ISIN : INE570L01029

  • Incorporation Year

    1999

  • Registered Office

    Plot #.DS-7 IKP Knowledge Park
    Turkapally (V) Shameerpet Md, Hyderabad,
    Telangana-500078

  • Telephone

    +91 40 6815 6000

  • FAX

  • Chairman

    Ranga Raju Kanumuri

  • Managing Director

    Krishnamraju Kanumuri

  • Company Secretary

    RUNA KUMAR

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Sai Life Sciences Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Sai Life 1,585.00 2,202.36 2,153.23 94.97 18.71
Abbott India 26,071.95 7,217.19 6,929.05 34.31 43.78
Astrazeneca Phar 6,930.80 2,304.07 2,275.58 102.15 27.86
Glaxosmi. Pharma 2,958.60 3,932.76 3,790.20 47.26 58.17
Novartis India 1,637.10 398.23 356.27 41.34 16.64
Cipla 1,385.00 20,102.60 18,979.95 36.40 13.88
Bliss GVS Pharma 668.70 773.53 729.81 62.09 12.51
Amrutanjan Healt 506.25 520.13 502.55 27.12 24.16
Fermenta Biotec. 498.35 474.15 450.25 23.27 18.77
Guj. Themis Bio. 411.75 152.47 150.80 110.09 27.21
Ambalal Sarabhai 43.72 19.52 3.94 80.96 6.77